A phenotypic screen of a compound library for antiparasitic activity on Trypanosoma brucei, the causative agent of human African trypanosomiasis, led to the identification of substituted 2-(3-aminophenyl)oxazolopyridines as a starting point for hit-to-lead medicinal chemistry. A total of 110 analogues were prepared, which led to the identification of 64, a substituted 2-(3-aminophenyl)imidazopyridine. This compound showed antiparasitic activity in vitro with an EC50 of 2 nM and displayed reasonable druglike properties when tested in a number of in vitro assays. The compound was orally bioavailable and displayed good plasma and brain exposure in mice. Compound 64 cured mice infected with Trypanosoma brucei when dosed orally down to 2.5 mg/kg. Given its potent antiparasitic properties and its ease of synthesis, compound 64 represents a new lead for the development of drugs to treat human African trypanosomiasis.
A phenotypic screen of a compound library for antiparn class="Chemical">asitic activity on Trypanosoma brucei, the causative agent of human African trypanosomiasis, led to the identification of substituted 2-(3-aminophenyl)oxazolopyridinesas a starting point for hit-to-lead medicinal chemistry. A total of 110 analogues were prepared, which led to the identification of 64, a substituted 2-(3-aminophenyl)imidazopyridine. This compound showed antiparasitic activity in vitro with an EC50 of 2 nM and displayed reasonable druglike properties when tested in a number of in vitro assays. The compound was orally bioavailable and displayed good plasma and brain exposure in mice. Compound 64 cured mice infected with Trypanosoma brucei when dosed orally down to 2.5 mg/kg. Given its potent antiparasitic properties and its ease of synthesis, compound 64 represents a new lead for the development of drugs to treat human African trypanosomiasis.
Authors: A M Aronov; S Suresh; F S Buckner; W C Van Voorhis; C L Verlinde; F R Opperdoes; W G Hol; M H Gelb Journal: Proc Natl Acad Sci U S A Date: 1999-04-13 Impact factor: 11.205
Authors: Christophe Dardonville; Michael P Barrett; Reto Brun; Marcel Kaiser; Farial Tanious; W David Wilson Journal: J Med Chem Date: 2006-06-15 Impact factor: 7.446
Authors: James M Kraus; Christophe L M J Verlinde; Mandana Karimi; Galina I Lepesheva; Michael H Gelb; Frederick S Buckner Journal: J Med Chem Date: 2009-03-26 Impact factor: 7.446
Authors: Pravin Bendale; Srinivas Olepu; Praveen Kumar Suryadevara; Vivek Bulbule; Kasey Rivas; Laxman Nallan; Brian Smart; Kohei Yokoyama; Sudha Ankala; Prakash Rao Pendyala; David Floyd; Louis J Lombardo; David K Williams; Frederick S Buckner; Debopam Chakrabarti; Christophe L M J Verlinde; Wesley C Van Voorhis; Michael H Gelb Journal: J Med Chem Date: 2007-08-28 Impact factor: 7.446
Authors: Wesley C Van Voorhis; Kasey L Rivas; Pravin Bendale; Laxman Nallan; Carolyn Hornéy; Lynn K Barrett; Kevin D Bauer; Brian P Smart; Sudha Ankala; Oliver Hucke; Christophe L M J Verlinde; Debopam Chakrabarti; Corey Strickland; Kohei Yokoyama; Frederick S Buckner; Andrew D Hamilton; David K Williams; Louis J Lombardo; David Floyd; Michael H Gelb Journal: Antimicrob Agents Chemother Date: 2007-07-02 Impact factor: 5.191
Authors: Andriy Buchynskyy; J Robert Gillespie; Matthew A Hulverson; Joshua McQueen; Sharon A Creason; Ranae M Ranade; Nicole A Duster; Michael H Gelb; Frederick S Buckner Journal: Bioorg Med Chem Date: 2016-11-12 Impact factor: 3.641
Authors: Wenlin Huang; Matthew A Hulverson; Ryan Choi; Samuel L M Arnold; Zhongsheng Zhang; Molly C McCloskey; Grant R Whitman; Robert C Hackman; Kasey L Rivas; Lynn K Barrett; Kayode K Ojo; Wesley C Van Voorhis; Erkang Fan Journal: J Med Chem Date: 2019-03-15 Impact factor: 7.446
Authors: Deborah A Schaefer; Dana P Betzer; Kylie D Smith; Zachary G Millman; Hannah C Michalski; Sarah E Menchaca; Jennifer A Zambriski; Kayode K Ojo; Matthew A Hulverson; Samuel L M Arnold; Kasey L Rivas; Rama S R Vidadala; Wenlin Huang; Lynn K Barrett; Dustin J Maly; Erkang Fan; Wesley C Van Voorhis; Michael W Riggs Journal: J Infect Dis Date: 2016-10-17 Impact factor: 5.226
Authors: Donald A Patrick; Tanja Wenzler; Sihyung Yang; Patrick T Weiser; Michael Zhuo Wang; Reto Brun; Richard R Tidwell Journal: Bioorg Med Chem Date: 2016-04-02 Impact factor: 3.641
Authors: A S G Nefertiti; M M Batista; P B Da Silva; D G J Batista; C F Da Silva; R B Peres; E C Torres-Santos; E F Cunha-Junior; E Holt; D W Boykin; R Brun; T Wenzler; M N C Soeiro Journal: Antimicrob Agents Chemother Date: 2018-01-25 Impact factor: 5.191
Authors: Matthew A Hulverson; Igor Bruzual; Erin V McConnell; Wenlin Huang; Rama S R Vidadala; Ryan Choi; Samuel L M Arnold; Grant R Whitman; Molly C McCloskey; Lynn K Barrett; Kasey L Rivas; Suzanne Scheele; Amy E DeRocher; Marilyn Parsons; Kayode K Ojo; Dustin J Maly; Erkang Fan; Wesley C Van Voorhis; J Stone Doggett Journal: J Infect Dis Date: 2019-04-16 Impact factor: 5.226
Authors: Pendem Nagendar; J Robert Gillespie; Zackary M Herbst; Ranae M Ranade; Nora M R Molasky; Omeed Faghih; Rachael M Turner; Michael H Gelb; Frederick S Buckner Journal: ACS Med Chem Lett Date: 2018-12-04 Impact factor: 4.345
Authors: Matthew A Hulverson; Sumiti Vinayak; Ryan Choi; Deborah A Schaefer; Alejandro Castellanos-Gonzalez; Rama S R Vidadala; Carrie F Brooks; Gillian T Herbert; Dana P Betzer; Grant R Whitman; Hayley N Sparks; Samuel L M Arnold; Kasey L Rivas; Lynn K Barrett; A Clinton White; Dustin J Maly; Michael W Riggs; Boris Striepen; Wesley C Van Voorhis; Kayode K Ojo Journal: J Infect Dis Date: 2017-04-15 Impact factor: 5.226